
News|Articles|April 11, 2025
A Turning Point in Retinal Neovascular Diseases
Author(s)Sponsored by Bayer
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
IGS 2026: Navigating MIGS and other modern glaucoma procedures
2
IGS 2026: The expanding role of artificial intelligence in ophthalmology
3
IGS 2026: Considering OCT in neuro-ophthalmology and neurological diseases
4
IGS 2026: Population-based normative data could transform AI in glaucoma
5




























